Condition
Cytomegalovirus Congenital
Total Trials
6
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown3
Completed2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04615715Not ApplicableActive Not Recruiting
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
NCT03090841UnknownPrimary
Biomarkers of Cytomegalovirus Fetal Infection and Disease
NCT04724265Not ApplicableUnknown
Cytomegalovirus (CMV) Perilymphatic Fluid
NCT04879784UnknownPrimary
Primary Prevention of Cytomegalovirus in Pregnancy: Addressing the Gaps (CMV GAP)
NCT03511274Not ApplicableCompletedPrimary
Reducing Acquisition of CMV Through Antenatal Education
NCT03722615CompletedPrimary
Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa
Showing all 6 trials